227 related articles for article (PubMed ID: 35532363)
1. The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
Nakauchi Y; Azizi A; Thomas D; Corces MR; Reinisch A; Sharma R; Cruz Hernandez D; Köhnke T; Karigane D; Fan A; Martinez-Krams D; Stafford M; Kaur S; Dutta R; Phan P; Ediriwickrema A; McCarthy E; Ning Y; Phillips T; Ellison CK; Guler GD; Bergamaschi A; Ku CJ; Levy S; Majeti R
Blood Cancer Discov; 2022 Jul; 3(4):346-367. PubMed ID: 35532363
[TBL] [Abstract][Full Text] [Related]
2. A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing.
Gjini E; Mansour MR; Sander JD; Moritz N; Nguyen AT; Kesarsing M; Gans E; He S; Chen S; Ko M; Kuang YY; Yang S; Zhou Y; Rodig S; Zon LI; Joung JK; Rao A; Look AT
Mol Cell Biol; 2015 Mar; 35(5):789-804. PubMed ID: 25512612
[TBL] [Abstract][Full Text] [Related]
3. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
4. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
[TBL] [Abstract][Full Text] [Related]
5. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
Jeong JJ; Gu X; Nie J; Sundaravel S; Liu H; Kuo WL; Bhagat TD; Pradhan K; Cao J; Nischal S; McGraw KL; Bhattacharyya S; Bishop MR; Artz A; Thirman MJ; Moliterno A; Ji P; Levine RL; Godley LA; Steidl U; Bieker JJ; List AF; Saunthararajah Y; He C; Verma A; Wickrema A
Cancer Discov; 2019 Jun; 9(6):778-795. PubMed ID: 30944118
[TBL] [Abstract][Full Text] [Related]
7. A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Guan Y; Tiwari AD; Phillips JG; Hasipek M; Grabowski DR; Pagliuca S; Gopal P; Kerr CM; Adema V; Radivoyevitch T; Parker Y; Lindner DJ; Meggendorfer M; Abazeed M; Sekeres MA; Mian OY; Haferlach T; Maciejewski JP; Jha BK
Blood Cancer Discov; 2021 Mar; 2(2):146-161. PubMed ID: 33681816
[No Abstract] [Full Text] [Related]
8. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
[TBL] [Abstract][Full Text] [Related]
9. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
Joshi K; Zhang L; Breslin S J P; Kini AR; Zhang J
J Exp Clin Cancer Res; 2022 Oct; 41(1):294. PubMed ID: 36203205
[TBL] [Abstract][Full Text] [Related]
10. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL
Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556
[TBL] [Abstract][Full Text] [Related]
11. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
[TBL] [Abstract][Full Text] [Related]
13. Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.
Meng C; Gu L; Li Y; Li R; Cao Y; Li Z; Allen EG; Zhu D; Jin P
Hum Mol Genet; 2021 Oct; 30(21):1985-1995. PubMed ID: 34165552
[TBL] [Abstract][Full Text] [Related]
14. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.
Cheng J; Guo S; Chen S; Mastriano SJ; Liu C; D'Alessio AC; Hysolli E; Guo Y; Yao H; Megyola CM; Li D; Liu J; Pan W; Roden CA; Zhou XL; Heydari K; Chen J; Park IH; Ding Y; Zhang Y; Lu J
Cell Rep; 2013 Oct; 5(2):471-81. PubMed ID: 24120864
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Corneal Epithelial Differentiation by TET2.
Sasamoto Y; Wu S; Lee CAA; Jiang JY; Ksander BR; Frank MH; Frank NY
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769164
[TBL] [Abstract][Full Text] [Related]
16. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
[TBL] [Abstract][Full Text] [Related]
17. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A
Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.
Stoyanova E; Riad M; Rao A; Heintz N
Elife; 2021 Dec; 10():. PubMed ID: 34919053
[TBL] [Abstract][Full Text] [Related]
19. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
[TBL] [Abstract][Full Text] [Related]
20. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
